FGF19 and cancer: MSCs-EVs molecules have been shown to transfer FGF19 to nasopharyngeal cancer cells, in turn, activating a FGF19-FGFR4-dependent ERK signaling pathway that stimulates cancer cell proliferation and migration [50].